InvestSMART

Skin Elements Limited (ASX: SKN) - Share Price

- Current share price for SKN : $0.006

Skin Elements Limited (SKN), an ASX-listed company, is an Australian owned and operated natural biotechnology company focused on the development of its SE FormulaTM Biotechnology. Its approach to research and development of plant-based and organic sourced ingredients has enabled the creation of a portfolio of all natural plant based formulations that have global applications.

SKN General Information +

ASX Code SKN
Website http://www.skinelementslimited.com
Industry/Sector Personal Products
Market Cap ($M) 19
SKN Share Price $0.006
Day High $0.006
Day Low $0.006
Last Close $0.006
SKN Share Price Movement - ( No change )
Prices as at 16:40, 17 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Skin Elements Limited (SKN) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Skin Elements Limited (SKN) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Skin Elements Limited (SKN) price-sensitive announcements

SKN - Execution of a Commercialisation Agreement with Farmlands
Skin Elements Limited has entered into an exclusive distribution agreement with Farmlands
Skin Elements Limited (SKN)
9 Jul 2026 | 9:24 AM
SKN - Trading Halt
On 7 July 2026, Skin Elements Limited (ASX: SKN) announced a trading halt on its securitie
Skin Elements Limited (SKN)
7 Jul 2026 | 9:03 AM
SKN - Skin Elements secures $900k Placement
Skin Elements Limited, an Australian biotechnology company, announced it has successfully
Skin Elements Limited (SKN)
26 Jun 2026 | 9:11 AM
SKN - Trading Halt
On 25 June 2026, trading in the securities of Skin Elements Limited (ASX: SKN) was halted
Skin Elements Limited (SKN)
25 Jun 2026 | 10:03 AM

Skin Elements Limited (SKN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Application for quotation of securities - SKN 9 Jul 2026 4:23PM $0.008 $0.006 fallen by 25%
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Execution of a Commercialisation Agreement with Farmlands 9 Jul 2026 9:24AM $0.005 $0.006 risen by 20%
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Trading Halt 7 Jul 2026 9:03AM $0.005 $0.006 risen by 20%
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Initial Director's Interest Notice x 3 26 Jun 2026 4:51PM $0.006 $0.006 fallen by 0%
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Final Director's Interest Notice x 3 26 Jun 2026 2:18PM $0.005 $0.006 risen by 20%
Skin Elements Limited (SKN)
ORDINARY FULLY PAID
 Consumer Staple $19 Proposed issue of securities - SKN 26 Jun 2026 9:11AM $0.005 $0.006 risen by 20%

SKN Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$1.73 -$0.20 -29.00% 0.00 0.00 0.00% 0.0%
2024A -$1.87 -$0.30 -141.90% 0.00 0.00 0.00% 0.0%
2023A -$4.10 $0.70 -300.00% 2.30 0.00 0.00% 0.0%

SKN Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Skin Elements Limited (SKN) $19M -0.2903 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

SKN Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -3.33 0.00
Market 0.30 13.10 1.14 0.59
Sector 0.00 200.00 0.94 0.00

SKN Directors

Name Position Start Date
Mr Peter Malone Executive Chairman, Executive Director 4 Sep 2015
Mr Harry Spindler Non-Executive Director 22 Jun 2026
Mr Frank Robert Knezovic Non-Executive Director 23 Jun 2026
Mr Alex John Poulsen Non-Executive Director 29 Oct 2020
Mr Joshua Gordon Non-Executive Director 24 Feb 2026
Mr Roderick (Rod) Anthony Nicholas Non-Executive Director 24 Feb 2026
Mr Gorakanage Ishan Malinda Peries Non-Executive Director 23 Jun 2026

Skin Elements Limited (SKN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
17 Dec 2025 MALONE, Peter Issued Indirect Shares 119,025,000 $0.006 $714,150.000
17 Dec 2025 MALONE, Peter Sell Indirect Shares 211,950,000 $0.005 $1,059,750.000
17 Dec 2025 MALONE, Peter Exercise Options 119,025,000 $0.006 $714,150.000

See all changes in directors' interest & trades for Skin Elements Limited (SKN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SKN Management

Name Position
Craig Piercy Chief Financial Officer
Leo Fung Chief Technical Advisor
Stuart Douglas Usher Company Secretary

SKN Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Skin Elements Limited (SKN). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
35,000,000 (6.21%) ABC Brightred Pty Ltd
31,743,116 (5.63%) Sovereign Empire Pty Ltd

SKN Calendar of Events

Date Event
26 February 2027 Report (Interim)
29 September 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.